SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001760292-18-000001
Filing Date
2018-11-29
Accepted
2018-11-29 16:22:03
Documents
1
Period of Report
2018-11-26

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 1466
  Complete submission text file 0001760292-18-000001.txt   2800
Mailing Address 7015 ALBERT EINSTEIN DRIVE COLUMBIA MD 21046
Business Address 7015 ALBERT EINSTEIN DRIVE COLUMBIA MD 21046 443-545-1819
OSIRIS THERAPEUTICS, INC. (Issuer) CIK: 0001360886 (see all company filings)

IRS No.: 710881115 | State of Incorp.: MD | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 5600 HIGHCROFT DRIVE CARY NC 27519
Business Address
Tom Samson (Reporting) CIK: 0001760292 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-32966 | Film No.: 181208700